Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Related Posts
Rastogi A, Magay Y, Kady Y. The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers. Adv Ther. 2026 Jul 30. doi:[...]
Inkong P, Lum EL, Kim K, Dhaliwal I, Zuckerman JE, Bunnapradist S. Graft Outcomes in For-Cause Biopsy-Proven Recurrent IgA Nephropathy After Kidney Transplantation: Rare but[...]
Kim Y, Cho WK, Song J, Evangelista LS, Kopple JD. Development and Psychometric Evaluation of the End-Stage Renal Disease Adherence Questionnaire-Short Form: English, Spanish, and[...]